Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
Studies To Approve Pediatric Use of Adult Drugs Often Have Serious Problems: Report October 1, 2015 Irvin Jackson Add Your Comments The findings of a new study warns that clinical trials designed to test whether drugs are safe and effective for children are not as stringent as they should be. In a report published in the medical journal The BMJ (formerly the British Medical Journal) on September 23, researchers indicate that there is a significant drop in the quality of clinical trials done to gain expanded FDA approval when compared to studies originally done to put the medications on the market, and the problem is particularly evident when it comes to pediatric uses. The FDA requires that any drug uses, whether new or an expansion of approved uses for an existing medication, must have clinical trial data backing up the indication. While it is common for doctors to prescribe medications “off-label” for specific purposes that may not be approved by the FDA, drug companies are prohibited from promoting such indications until they have established that it is safe and effective. Do You Know about… SPORTS BETTING ADDICTION LAWSUITS FOR YOUNG ADULTS Gambling addiction and severe financial losses have been linked to popular sports betting platforms like DraftKings, FanDuel, and Caesars. Lawsuits are being filed by young adults and students who were targeted by deceptive promotions, addictive app features, and aggressive marketing tactics. See if you qualify for a sports betting addiction lawsuit. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Do You Know About… SPORTS BETTING ADDICTION LAWSUITS FOR YOUNG ADULTS Gambling addiction and severe financial losses have been linked to popular sports betting platforms like DraftKings, FanDuel, and Caesars. Lawsuits are being filed by young adults and students who were targeted by deceptive promotions, addictive app features, and aggressive marketing tactics. See if you qualify for a sports betting addiction lawsuit. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Researchers with Brigham and Women’s Hospital in Boston looked at publicly accessible data on what are known as supplemental indications, which are when a drug company seeks to expand the approved uses of an existing drug. For approvals issued by the FDA between 2005 and 2014, researchers found 295 such supplemental indications. According to the findings, only 30% of supplemental approvals for totally new drug uses were supported by efficacy trials with active comparators. That compares to 51% for modified use approvals and only 11% in cases where the company sought to expand the population, such as approval for use by children. “Supplements that expanded a drugs approved patient population were supported by the fewest active comparator trials and studies using clinical outcome endpoints,” the researchers noted. “Almost all of the supplements expanding a drug’s approved patient population were for pediatric patients, and nearly half of these supplemental indication approvals were supported by uncontrolled studies or no additional clinical studies, with approval based on extrapolation from adult studies alone.” Researchers say they did not go far enough to conclude that any of the indications for pediatric use of adult drugs were mistaken, but noted that children have “unique physiologies and pharmacokinetic characteristics” that require drug companies do additional trials that are separate from tests done on adults. Part of the problem may be that drug companies that get pediatric approval for existing drugs receive an additional six months of market exclusivity on that drug, meaning that they can hold the patent for an additional half year before generic versions are allowed to enter the market. 21st Century Cures Bill May Make Situation Worse The study also warns that recent legislation known as the 21st Century Cures, which was recently passed by the House of Representatives and promises to make drug approval testing even less stringent, could result in even less rigorous testing of pediatric uses. Consumer advocates have previously raised concerns that the FDA is not adequately protecting patients from dangerous drugs and medical devices, often failing to require stringent premarket studies to identify dangerous side effects or defects before the wide use of new treatments. Despite questions about the latitude already provided to manufacturers, the bill would further loosen the approval process by allowing the agency to approve drugs and medical devices that have not had clinical trials, critics warn. The bill comes amid a push for drug companies to release clinical trial data following incidents of ghost-writing and study-tampering that has involved powerful drugs that were later approved by the FDA. Independent researchers warn that in some cases it appears the agency was outright lied to about adverse events and effectiveness of drugs in company-sponsored clinical trials. In February, a study found that the FDA was finding evidence of clinical trial fraud, but not reporting it in most cases. Supporters of the bill say more flexibility in the FDA approval requirements is necessary to speed up the process of getting vital drugs to patients in a timely manner. Tags: Childrens Drugs, Clinical Trials, Congress More Lawsuit Stories Lawyers To Select 50 Suboxone Dental Lawsuits for Next Phase of MDL Bellwether Discovery May 22, 2025 Talc Safety To Be Subject of New Independent Scientific Expert Panel Led by FDA May 22, 2025 GeekVape Aegis Lawsuit Filed Over Severe Burns Caused by Vape Pen Explosion May 22, 2025 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermPhoneThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Lawyers To Select 50 Suboxone Dental Lawsuits for Next Phase of MDL Bellwether Discovery (Posted: today) As lawyers continue to review records on more than 500 Suboxone tooth decay lawsuits, the MDL judge has outlined the process for identifying a smaller group that will move into the next discovery phase. MORE ABOUT: SUBOXONE TOOTH DECAY LAWSUIT500 Suboxone Tooth Decay Cases Randomly Selected for Bellwether Record Collection Pool (04/24/2025)Status of Suboxone Tooth Loss Lawsuits To Be Reviewed at MDL Conference (04/16/2025)Prenatal Opioid Exposure May Result in Smaller Brains Among Newborns: Study (04/14/2025) Hair Relaxer Lawsuits MDL Judge Seeks Status Report on Discovery Proceedings (Posted: yesterday) A federal judge wants lawyers involved in hair relaxer lawsuits to provide an update this week on the status of discovery proceedings for a pool of cases being considered for bellwether trial dates. MORE ABOUT: HAIR RELAXER LAWSUITFormaldehyde Found in Range of Personal Care Products Used Primarily by Black and Latina Women (05/14/2025)Lawyers Selected 32 Hair Relaxer Lawsuits for Bellwether Discovery in MDL (05/13/2025)Hair Relaxer Settlement Master Appointed To Oversee Negotiations To Resolve Cancer Lawsuits (04/29/2025) Covidien Parietex Optimized Composite (PCOx) Hernia Mesh Lawsuits To Be Prepared for Trial (Posted: yesterday) Two Covidien Parietex Optimized Composite hernia mesh lawsuits have been chosen to be prepared to potentially serve as the third Covidien hernia mesh bellwether trial. MORE ABOUT: HERNIA MESH LAWSUITSecond Bellwether Trial in Covidien Hernia Mesh Lawsuit MDL Set for July 2026 (05/14/2025)Covidien Mesh Lawsuit Set For Trial in Feb. 2026, Over Defective Hernia Implant (04/10/2025)New Bard Hernia Mesh Lawsuits Continue To Be Filed Following Global Settlement (04/03/2025)
Lawyers To Select 50 Suboxone Dental Lawsuits for Next Phase of MDL Bellwether Discovery May 22, 2025
Lawyers To Select 50 Suboxone Dental Lawsuits for Next Phase of MDL Bellwether Discovery (Posted: today) As lawyers continue to review records on more than 500 Suboxone tooth decay lawsuits, the MDL judge has outlined the process for identifying a smaller group that will move into the next discovery phase. MORE ABOUT: SUBOXONE TOOTH DECAY LAWSUIT500 Suboxone Tooth Decay Cases Randomly Selected for Bellwether Record Collection Pool (04/24/2025)Status of Suboxone Tooth Loss Lawsuits To Be Reviewed at MDL Conference (04/16/2025)Prenatal Opioid Exposure May Result in Smaller Brains Among Newborns: Study (04/14/2025)
Hair Relaxer Lawsuits MDL Judge Seeks Status Report on Discovery Proceedings (Posted: yesterday) A federal judge wants lawyers involved in hair relaxer lawsuits to provide an update this week on the status of discovery proceedings for a pool of cases being considered for bellwether trial dates. MORE ABOUT: HAIR RELAXER LAWSUITFormaldehyde Found in Range of Personal Care Products Used Primarily by Black and Latina Women (05/14/2025)Lawyers Selected 32 Hair Relaxer Lawsuits for Bellwether Discovery in MDL (05/13/2025)Hair Relaxer Settlement Master Appointed To Oversee Negotiations To Resolve Cancer Lawsuits (04/29/2025)
Covidien Parietex Optimized Composite (PCOx) Hernia Mesh Lawsuits To Be Prepared for Trial (Posted: yesterday) Two Covidien Parietex Optimized Composite hernia mesh lawsuits have been chosen to be prepared to potentially serve as the third Covidien hernia mesh bellwether trial. MORE ABOUT: HERNIA MESH LAWSUITSecond Bellwether Trial in Covidien Hernia Mesh Lawsuit MDL Set for July 2026 (05/14/2025)Covidien Mesh Lawsuit Set For Trial in Feb. 2026, Over Defective Hernia Implant (04/10/2025)New Bard Hernia Mesh Lawsuits Continue To Be Filed Following Global Settlement (04/03/2025)